RE:RE:RE:WELCOME TO A NEW BIO-PHARMACEUTICAL COMPANY! Taurus62 wrote: Nick,
I've seen the 'Seeking Alpha' article before as I'm a subscriber. However, I disagree with the summary and conclusion. Therefore, I'll make my own judgement and financial decision on PLI. IN my opinion, PLI has never been a better buy than now!
Taurus62
As you disagree with the article's summary and conclusion, I wonder if you have read my previous
SA article that analysed their April 1 Q4 report In this previous article, I estimated that the fundementals of Prometic has changed for the worse. The recent event has further confirmed my observation since the article was published.
Firstly, the company withheld CRL from the investors for a year. It's quite possible, imo, that they also under-stated the extend of the improvement on CMC data that is required by the FDA, and therefore it is very risky, imo, that they lack the competence to correct the problem.
Therefore, the re-submission/approval is far from being a sure thing.
Secondly, 4050's progress has been halted, or gone back, while the competition is now much further ahead.
Therefore, imo, this stock is at best a HOLD, for those who have already invested.
For new investors and those such as yourself, who don't mind how SALP comes to be the majority sharehholder, remember to not over-estimate the competence of those involved, and under-estimate what lays ahead.
Two recent examples (SGPY, AKAO) of US small cap biotech gent bankrupt, one year after their first drug being approved, showed the level of difficulties, in spite of early promises, and being listed on NASDAQ and well supported by retails/tutes investors alike, up to the point of failures.